Literature DB >> 23367687

Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas.

Mayumi Nakagawa, Horace J Spencer, Hannah N Coleman, William W Greenfield.   

Abstract

The distribution of human papillomavirus (HPV) types and T-cell immune responses were compared among European American, African American, and Hispanic American populations being followed for abnormal Papanicolaou smear results who were attending the same university medical center clinic in Central Arkansas. Statistically significant differences were found for HPV types 55, 58, and 83 among the 37 HPV types tested. However, there were no differences in T-cell immune responses among these racial/ethnic groups. These results are unlikely to have an impact on therapeutic HPV vaccine development since the most prevalent HPV type among all racial/ethnic groups was HPV type 16.

Entities:  

Mesh:

Year:  2013        PMID: 23367687      PMCID: PMC3594117     

Source DB:  PubMed          Journal:  J Ark Med Soc        ISSN: 0004-1858


  9 in total

1.  Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Authors:  Cosette M Wheeler; Xavier Castellsagué; Suzanne M Garland; Anne Szarewski; Jorma Paavonen; Paulo Naud; Jorge Salmerón; Song-Nan Chow; Dan Apter; Henry Kitchener; Júlio C Teixeira; S Rachel Skinner; Unnop Jaisamrarn; Genara Limson; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; F Xavier Bosch; Diane M Harper; Warner Huh; Karin Hardt; Toufik Zahaf; Dominique Descamps; Frank Struyf; Gary Dubin; Matti Lehtinen
Journal:  Lancet Oncol       Date:  2011-11-08       Impact factor: 41.316

2.  Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.

Authors:  Iain J Macleod; Belinda O'Donnell; Sikhulile Moyo; Shahin Lockman; Roger L Shapiro; Mukendi Kayembe; Erik van Widenfelt; Joseph Makhema; M Essex; Carolyn Wester
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

3.  A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being studied for abnormal pap smear results.

Authors:  Mayumi Nakagawa; Sushil K Gupta; Hannah N Coleman; Matthew A Sellers; Joseph A Banken; William W Greenfield
Journal:  J Low Genit Tract Dis       Date:  2010-04       Impact factor: 1.925

4.  Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

Authors:  Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

5.  CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.

Authors:  Kevin H Kim; William W Greenfield; Martin J Cannon; Hannah N Coleman; Horace J Spencer; Mayumi Nakagawa
Journal:  Cancer Immunol Immunother       Date:  2011-08-13       Impact factor: 6.968

6.  Identification of human papillomavirus type 58 lineages and the distribution worldwide.

Authors:  Paul K S Chan; Alfred C S Luk; Jong-Sup Park; Karen K Smith-McCune; Joel M Palefsky; Ryo Konno; Lucia Giovannelli; Francois Coutlée; Samantha Hibbitts; Tang-Yuan Chu; Wannapa Settheetham-Ishida; María Alejandra Picconi; Annabelle Ferrera; Federico De Marco; Yin-Ling Woo; Tainá Raiol; Patricia Piña-Sánchez; Jo L K Cheung; Jeong-Hoon Bae; Mike Z Chirenje; Tsitsi Magure; Anna-Barbara Moscicki; Alison N Fiander; Rosa Di Stefano; Tak-Hong Cheung; May M Y Yu; Stephen K W Tsui; David Pim; Lawrence Banks
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

7.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

8.  Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.

Authors:  Karen K Smith-McCune; Stephen Shiboski; Mike Z Chirenje; Tsitsi Magure; Jennifer Tuveson; Yifei Ma; Maria Da Costa; Anna-Barbara Moscicki; Joel M Palefsky; Rudo Makunike-Mutasa; Tsungai Chipato; Ariane van der Straten; George F Sawaya
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

Review 9.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

  9 in total
  6 in total

1.  Efficacy of pulsed dye laser treatment for common warts is not influenced by the causative HPV type: a prospective study.

Authors:  Yoseph Fichman; Assi Levi; Emmilia Hodak; Shlomit Halachmi; Sigal Mazor; Dana Wolf; Orit Caplan; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2017-12-07       Impact factor: 3.161

2.  Elimination of Cancer Health Disparities through the Acceleration of HPV Vaccines and Vaccinations: A Simplified Version of the President's Cancer Panel Report on HPV Vaccinations.

Authors:  Eva McGhee; Hill Harper; Adaku Ume; Melanie Baker; Cheick Diarra; John Uyanne; Sebhat Afework; Keosha Partlow; Lucy Tran; Judith Okoro; Anh Doan; Karen Tate; Mechelle Rouse; Meidrah Tyler; Kamilah Evans; Tonya Sanchez; Ishmum Hasan; Enijah Smith-Joe; Jasmine Maniti; Liliana Zarate; Camille King; Antoinette Alugbue; Chiamaka Opara; Bileko Wissa; Joanne Maniti; Roland Pattillo
Journal:  J Vaccines Vaccin       Date:  2017-05-29

3.  HPV Prevalence and Genotype Distribution Among Women From Hengyang District of Hunan Province, China.

Authors:  Shuang-Yang Tang; Ya-Qi Liao; Yu Hu; Hai-Yan Shen; Yan-Ping Wan; Yi-Mou Wu
Journal:  Front Public Health       Date:  2021-11-05

4.  Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, China.

Authors:  Z Baloch; T Yuan; S Yindi; Y Feng; W Tai; Y Liu; L Liu; A Zhang; B Wang; X Wu; X Xia
Journal:  Braz J Med Biol Res       Date:  2016-05-31       Impact factor: 2.590

5.  The Prevalence of Genital Human Papillomavirus Subtypes in a Cohort of Hispanic Women Presenting for Cervical Cancer Screening Along the US-Mexico Border.

Authors:  Navkiran K Shokar; Amy Doan; Jessica Calderon-Mora; Rajkumar Lakshmanaswamy; Subramani Ramadevi; Gurjeet S Shokar; Jennifer Molokwu; Adam Alomari; Alok Dwivedi
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

6.  Prevalence and risk factors for human papillomavirus infection among Chinese ethnic women in southern of Yunnan, China.

Authors:  Zulqarnain Baloch; Nafeesa Yasmeen; Yuanyue Li; Ke Ma; Xiaomei Wu; Shi-Hua Yang; Xueshan Xia
Journal:  Braz J Infect Dis       Date:  2017-03-08       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.